Africa Corporate Wellness Market, by End User, 2018-2027
| Label | Cannabidiol | Tetrahydrocannabinol |
|---|---|---|
| 2018 | 5.49 USD Mn | 2.08 USD Mn |
| 2019 | 21.77 USD Mn | 8.26 USD Mn |
| 2020 | 45.38 USD Mn | 17.28 USD Mn |
| 2021 | 76.3 USD Mn | 29.15 USD Mn |
| 2022 | 115.27 USD Mn | 44.17 USD Mn |
| 2023 | 166.16 USD Mn | 63.86 USD Mn |
| 2024 | 232.84 USD Mn | 89.77 USD Mn |
| 2025 | 331.59 USD Mn | 128.23 USD Mn |
| 2026 | 436.23 USD Mn | 169.22 USD Mn |
| 2027 | 561.84 USD Mn | 218.6 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027 portion of the Middle East & Africa Medical Cannabis Market, by Derivative, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 605 Mn in 2026 and is projected to reach USD 780 Mn by 2027 — a gain of about 29% over the forecast period, translating to a CAGR in the double digits.
- Of the 2 groups compared here, Cannabidiol is out front by 2027 at 561. 84M USD — 72% of the group total.
- What the regional split looks like (2026): Cannabidiol leads, holding roughly 72% of segment value — the single largest regional share. Tetrahydrocannabinol is the second-largest contributor.
- By 2027, Cannabidiol alone is expected to reach USD 562 Mn, with Tetrahydrocannabinol at USD 219 Mn.
Market Dynamics
Of the 2 groups compared here, Cannabidiol is out front by 2027 at 561.84M USD — 72% of the group total.
Tetrahydrocannabinol is runner-up at 218.60M USD — 61% off the lead.
Cannabidiol: 5.49M USD in 2018 to 561.84M USD by 2027, up 10134%.
Tetrahydrocannabinol grows to 218.60M USD by 2027, from 2.08M USD in 2018 — 10410% up.
By rate of change, not size, Tetrahydrocannabinol is the standout — 10410% growth, faster than the rest of the group.
The 2-group total: 7.57M USD in 2018, 780.44M USD by 2027, 10210% overall.
How The 2 Series Compare
This is a comparison chart, 2 groups at once — the interesting question is usually how the gap between them changes, not the value of any single group in isolation.
Do not confuse "biggest" with "fastest-growing" — they are frequently different series on a chart like this one, and the gap between them can close faster than the current ranking suggests.
For planning purposes, the end-year figure and the growth rate are the two numbers that matter. Together they show how large the Middle East & Africa Medical Cannabis market is projected to become and how quickly it gets there.
The numbers here come from a market sizing model: historical revenue estimates up to the 2018 base year, then forecasts through 2027 using growth-rate assumptions for each segment. The underlying report explains the methodology in detail.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



